GENinCode (GENI) Competitors GBX 1.10 0.00 (0.00%) As of 05/22/2026 12:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock GENI vs. EDR, AMC, DIS, LION, and SPHRShould you buy GENinCode stock or one of its competitors? MarketBeat compares GENinCode with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GENinCode include Egdon Resources (EDR), Amur Minerals (AMC), Distil (DIS), Lionsgold (LION), and Sphere Medical (SPHR). These companies are all part of the "entertainment" industry. GENI vs. EDRGENI vs. AMCGENI vs. DISGENI vs. LIONGENI vs. SPHRHow does GENinCode compare to Egdon Resources?Egdon Resources (LON:EDR) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations. Do institutionals & insiders believe in EDR or GENI? 18.6% of Egdon Resources shares are held by institutional investors. Comparatively, 4.8% of GENinCode shares are held by institutional investors. 63.8% of Egdon Resources shares are held by company insiders. Comparatively, 8.6% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, EDR or GENI? Egdon Resources has a beta of -0.25, indicating that its stock price is 125% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.608, indicating that its stock price is 39% less volatile than the broader market. Does the media favor EDR or GENI? In the previous week, Egdon Resources' average media sentiment score of 0.00 equaled GENinCode'saverage media sentiment score. Company Overall Sentiment Egdon Resources Neutral GENinCode Neutral Which has preferable earnings and valuation, EDR or GENI? Egdon Resources has higher revenue and earnings than GENinCode. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEgdon Resources£8.08M0.00£2.51MN/AN/AGENinCode£2.91M2.74-£6.10M-£2.35N/A Is EDR or GENI more profitable? Egdon Resources has a net margin of 31.06% compared to GENinCode's net margin of -170.49%. Egdon Resources' return on equity of 8.26% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets Egdon Resources31.06% 8.26% 4.22% GENinCode -170.49%-262.16%-63.99% SummaryEgdon Resources beats GENinCode on 8 of the 9 factors compared between the two stocks.How does GENinCode compare to Amur Minerals?Amur Minerals (LON:AMC) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk. Which has more volatility and risk, AMC or GENI? Amur Minerals has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.608, suggesting that its share price is 39% less volatile than the broader market. Does the media refer more to AMC or GENI? In the previous week, Amur Minerals' average media sentiment score of 0.00 equaled GENinCode'saverage media sentiment score. Company Overall Sentiment Amur Minerals Neutral GENinCode Neutral Is AMC or GENI more profitable? Amur Minerals has a net margin of 0.00% compared to GENinCode's net margin of -170.49%. Amur Minerals' return on equity of -14.97% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets Amur MineralsN/A -14.97% -7.77% GENinCode -170.49%-262.16%-63.99% Do institutionals & insiders have more ownership in AMC or GENI? 4.8% of GENinCode shares are held by institutional investors. 1.5% of Amur Minerals shares are held by company insiders. Comparatively, 8.6% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, AMC or GENI? Amur Minerals has higher earnings, but lower revenue than GENinCode. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmur MineralsN/AN/A-£2.39MN/AN/AGENinCode£2.91M2.74-£6.10M-£2.35N/A SummaryGENinCode beats Amur Minerals on 5 of the 9 factors compared between the two stocks.How does GENinCode compare to Distil?GENinCode (LON:GENI) and Distil (LON:DIS) are both small-cap entertainment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings. Do insiders and institutionals believe in GENI or DIS? 4.8% of GENinCode shares are owned by institutional investors. Comparatively, 0.0% of Distil shares are owned by institutional investors. 8.6% of GENinCode shares are owned by company insiders. Comparatively, 22.8% of Distil shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to GENI or DIS? In the previous week, GENinCode's average media sentiment score of 0.00 equaled Distil'saverage media sentiment score. Company Overall Sentiment GENinCode Neutral Distil Neutral Which has more volatility and risk, GENI or DIS? GENinCode has a beta of 0.608, meaning that its share price is 39% less volatile than the broader market. Comparatively, Distil has a beta of 0.184, meaning that its share price is 82% less volatile than the broader market. Is GENI or DIS more profitable? Distil has a net margin of -126.58% compared to GENinCode's net margin of -170.49%. Distil's return on equity of -21.81% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets GENinCode-170.49% -262.16% -63.99% Distil -126.58%-21.81%-7.50% Which has stronger valuation & earnings, GENI or DIS? Distil has lower revenue, but higher earnings than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGENinCode£2.91M2.74-£6.10M-£2.35N/ADistil£963K0.90-£2.19M-£0.08N/A SummaryDistil beats GENinCode on 6 of the 11 factors compared between the two stocks.How does GENinCode compare to Lionsgold?GENinCode (LON:GENI) and Lionsgold (LON:LION) are both entertainment companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Which has higher valuation & earnings, GENI or LION? Lionsgold has lower revenue, but higher earnings than GENinCode. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGENinCode£2.91M2.74-£6.10M-£2.35N/ALionsgoldN/AN/AN/AN/AN/A Does the media prefer GENI or LION? In the previous week, GENinCode's average media sentiment score of 0.00 equaled Lionsgold'saverage media sentiment score. Company Overall Sentiment GENinCode Neutral Lionsgold Neutral Do insiders & institutionals have more ownership in GENI or LION? 4.8% of GENinCode shares are held by institutional investors. 8.6% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is GENI or LION more profitable? Lionsgold has a net margin of 0.00% compared to GENinCode's net margin of -170.49%. Lionsgold's return on equity of 0.00% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets GENinCode-170.49% -262.16% -63.99% Lionsgold N/A N/A N/A SummaryGENinCode and Lionsgold tied by winning 3 of the 6 factors compared between the two stocks.How does GENinCode compare to Sphere Medical?GENinCode (LON:GENI) and Sphere Medical (LON:SPHR) are both entertainment companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends. Which has better valuation & earnings, GENI or SPHR? Sphere Medical has lower revenue, but higher earnings than GENinCode. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGENinCode£2.91M2.74-£6.10M-£2.35N/ASphere MedicalN/AN/AN/AN/AN/A Does the media prefer GENI or SPHR? In the previous week, GENinCode's average media sentiment score of 0.00 equaled Sphere Medical'saverage media sentiment score. Company Overall Sentiment GENinCode Neutral Sphere Medical Neutral Is GENI or SPHR more profitable? Sphere Medical has a net margin of 0.00% compared to GENinCode's net margin of -170.49%. Sphere Medical's return on equity of 0.00% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets GENinCode-170.49% -262.16% -63.99% Sphere Medical N/A N/A N/A Do institutionals and insiders have more ownership in GENI or SPHR? 4.8% of GENinCode shares are owned by institutional investors. 8.6% of GENinCode shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryGENinCode and Sphere Medical tied by winning 3 of the 6 factors compared between the two stocks. Get GENinCode News Delivered to You Automatically Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENI vs. The Competition ExportMetricGENinCodeDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£7.98M£67.56M£6.38B£3.03BDividend YieldN/A3.28%2.76%6.10%P/E Ratio-0.470.7921.04365.89Price / Sales2.74620.24557.9587,843.39Price / Cash0.8311.4244.5727.89Price / Book0.683.4210.377.69Net Income-£6.10M£334.07B£3.56B£5.89B7 Day PerformanceN/A-3.29%5.11%8.05%1 Month Performance-12.00%-2.48%3.59%2.82%1 Year Performance-26.81%8.69%34.19%77.61% GENinCode Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENIGENinCodeN/AGBX 1.10flatN/A-31.2%£7.98M£2.91MN/A2,300Gap UpEDREgdon ResourcesN/AN/AN/AN/A£24.88M£8.08M220.0011,000AMCAmur MineralsN/AN/AN/AN/A£1.25MN/AN/A33,700DISDistilN/AGBX 0.04-17.8%N/A-55.5%£753K£963KN/A220,000LIONLionsgoldN/AN/AN/AN/A£0.00N/AN/A2,021 Related Companies and Tools Related Companies EDR Competitors AMC Competitors DIS Competitors LION Competitors SPHR Competitors GVC Competitors TKO Competitors NFC Competitors MCS Competitors RDI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:GENI) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
